DSP-2230 is the orally active inhibitor for voltage-gated sodium channel that inhibits Nav1.7-, Nav1.8-, and Nav1.9-derived sodium currents with IC50s of 7.1 µM, 11.4 µM and 6.7 µM, respectively. DSP-2230 can be used to improve neuropathic pain[1][2][3][4].
Molecular Weight:
419.40
Purity:
98.33
CAS Number:
[1233231-30-5]
Formula:
C20H20F3N5O2
Target:
Sodium Channel
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted